BridgeMD
New treatment option for Miscarriage
Official title Use of Aromatase Inhibitor Before Misoprostol in Medical Termination of Miscarriage
ClinicalTrials.gov ID: NCT07109947
What this study is testing
What is Letrozole 2.5mg?
Letrozole 2.5mg is an investigational medicine, being studied as a potential treatment for miscarriage.
Also referred to as Misoprestol.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Abortion is one of the most common complications of pregnancy. Missed abortion is a type of abortions, occurs in 15%-20% of clinically diagnosed pregnancies and is defined as the retention of pregnancy products in the uterus for several days or weeks after death of the fetus.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 45, women only
You may be able to join if
- Missed or anembryonic pregnancy.
- Gestational age from 4 weeks to 26 weeks of pregnancy (confirmed by ultrasound scanning on first day of admittance).
- Hemoglobin level more than 9g/l.
- Closed cervix.
- No product of conception in the cervical canal.
You likely can't join if
- Previous attempt to terminate the pregnancy.
- Molar pregnancy
- Abnormal uterine lesions such as fibroids or congenital mal formations.
- Pregnancy despite of intrauterine contraceptive device.
- Medical disorders as cardiac, renal or hemorrhagic diseases.
- BMI more than 35 kg/m2.
See the full eligibility criteria
- Missed or anembryonic pregnancy.
- Gestational age from 4 weeks to 26 weeks of pregnancy (confirmed by ultrasound scanning on first day of admittance).
- Hemoglobin level more than 9g/l.
- Closed cervix.
- No product of conception in the cervical canal.
- Previous attempt to terminate the pregnancy.
- Molar pregnancy
- Abnormal uterine lesions such as fibroids or congenital mal formations.
- Pregnancy despite of intrauterine contraceptive device.
- Medical disorders as cardiac, renal or hemorrhagic diseases.
- BMI more than 35 kg/m2.
- Known hypersensitivity to any of the medication used.
The study team makes the final eligibility decision.
Where it's taking place
- Aswān, Egypt
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 45 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Aswān, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.